Display options
Cite
Sun J, Zhao Y, Qin L, et al. Metabolomic Profiles for HBV Related Hepatocellular Carcinoma Including Alpha-Fetoproteins Positive and Negative Subtypes. Front Oncol. 2019;9:1069doi: 10.3389/fonc.2019.01069.
Sun, J., Zhao, Y., Qin, L., Li, K., Zhao, Y., Sun, H., Zhang, T., & Zhang, Y. (2019). Metabolomic Profiles for HBV Related Hepatocellular Carcinoma Including Alpha-Fetoproteins Positive and Negative Subtypes. Frontiers in oncology, 91069. https://doi.org/10.3389/fonc.2019.01069
Sun, Jianping, et al. "Metabolomic Profiles for HBV Related Hepatocellular Carcinoma Including Alpha-Fetoproteins Positive and Negative Subtypes." Frontiers in oncology vol. 9 (2019): 1069. doi: https://doi.org/10.3389/fonc.2019.01069
Sun J, Zhao Y, Qin L, Li K, Zhao Y, Sun H, Zhang T, Zhang Y. Metabolomic Profiles for HBV Related Hepatocellular Carcinoma Including Alpha-Fetoproteins Positive and Negative Subtypes. Front Oncol. 2019 Oct 15;9:1069. doi: 10.3389/fonc.2019.01069. eCollection 2019. PMID: 31681602; PMCID: PMC6803550.
Copy Download .nbib Format: NLM
Share it on

Front Oncol. 2019 Oct 15;9:1069. doi: 10.3389/fonc.2019.01069. eCollection 2019.

Metabolomic Profiles for HBV Related Hepatocellular Carcinoma Including Alpha-Fetoproteins Positive and Negative Subtypes.

Frontiers in oncology

Jianping Sun, Yanan Zhao, Ling Qin, Kang Li, Yan Zhao, Huanqin Sun, Ting Zhang, Yonghong Zhang

Affiliations

  1. Beijing You'an Hospital, Capital Medical University, Beijing, China.
  2. NHC Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

PMID: 31681602 PMCID: PMC6803550 DOI: 10.3389/fonc.2019.01069

[No abstract available.]

Copyright © 2019 Sun, Zhao, Qin, Li, Zhao, Sun, Zhang and Zhang.

Keywords: HBV; alpha-fetoproteins; biomarkers; hepatocellular carcinomas; metabolomics

References

  1. Oncotarget. 2017 Mar 14;8(11):18177-18184 - PubMed
  2. Anal Chim Acta. 2012 Sep 19;743:90-100 - PubMed
  3. Can J Gastroenterol Hepatol. 2018 Apr 1;2018:9049252 - PubMed
  4. Hepatology. 2018 Feb;67(2):662-675 - PubMed
  5. Gastroenterology. 2004 Nov;127(5 Suppl 1):S113-9 - PubMed
  6. J Hepatol. 2014 May;60(5):995-1001 - PubMed
  7. Int J Cancer. 2015 Oct 15;137(8):1818-29 - PubMed
  8. Expert Rev Gastroenterol Hepatol. 2017 Jun;11(6):549-558 - PubMed
  9. Gastroenterology. 2012 May;142(6):1264-1273.e1 - PubMed
  10. Nature. 2019 Mar;567(7747):257-261 - PubMed
  11. World J Gastroenterol. 2015 Apr 28;21(16):4933-45 - PubMed
  12. Med J Aust. 2018 Oct 15;209(8):348-354 - PubMed
  13. Clin Chim Acta. 2016 Dec 1;463:39-44 - PubMed
  14. Science. 2009 May 22;324(5930):1029-33 - PubMed
  15. Curr Opin Clin Nutr Metab Care. 2009 May;12(3):223-6 - PubMed
  16. J Thorac Dis. 2015 Oct;7(10):1806-16 - PubMed
  17. Biomed Res Int. 2015;2015:274585 - PubMed
  18. Chin J Cancer Res. 2018 Feb;30(1):1-12 - PubMed
  19. Cancer Cell. 2017 Dec 11;32(6):807-823.e12 - PubMed
  20. Front Pharmacol. 2018 Aug 22;9:884 - PubMed
  21. Hepat Oncol. 2017 Oct;4(4):111-122 - PubMed
  22. J Hepatol. 2018 Jul;69(1):182-236 - PubMed
  23. Mol Cell Proteomics. 2011 Jul;10(7):M110.004945 - PubMed
  24. Rapid Commun Mass Spectrom. 2008 Oct;22(19):3061-8 - PubMed
  25. J Pathol. 2015 Jan;235(2):355-67 - PubMed
  26. Hepatology. 2018 Apr;67(4):1560-1599 - PubMed
  27. Int J Cancer. 2006 Jun 15;118(12):3030-44 - PubMed
  28. J Biol Chem. 2010 Apr 16;285(16):12241-7 - PubMed
  29. Am J Clin Nutr. 2006 Jun;83(6):1345-50 - PubMed
  30. Hepatology. 2013 May;57(5):2072-7 - PubMed

Publication Types